Khiron Life Sciences Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
KHRNF has 232.41 million shares outstanding.
| Current Share Class | 232.41M |
| Shares Outstanding | 232.41M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +15.06% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.00% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | 0.00 |
| P/TBV Ratio | 0.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 0.09.
| Current Ratio | 2.02 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.15 |
| Interest Coverage | -39.01 |
Financial Efficiency
Return on equity (ROE) is -74.68% and return on invested capital (ROIC) is -25.17%.
| Return on Equity (ROE) | -74.68% |
| Return on Assets (ROA) | -20.79% |
| Return on Invested Capital (ROIC) | -25.17% |
| Return on Capital Employed (ROCE) | -59.33% |
| Weighted Average Cost of Capital (WACC) | 13.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.31 |
| Inventory Turnover | 0.96 |
Taxes
| Income Tax | -267,308 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 21.99 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 46.71 |
| Average Volume (20 Days) | 161,683 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.30 |
Income Statement
In the last 12 months, KHRNF had revenue of 11.75 million and -22.33 million in losses. Loss per share was -0.12.
| Revenue | 11.75M |
| Gross Profit | 4.86M |
| Operating Income | -12.70M |
| Pretax Income | -22.60M |
| Net Income | -22.33M |
| EBITDA | -11.95M |
| EBIT | -12.70M |
| Loss Per Share | -0.12 |
Balance Sheet
The company has 1.41 million in cash and 1.87 million in debt, with a net cash position of -455,953 or -0.00 per share.
| Cash & Cash Equivalents | 1.41M |
| Total Debt | 1.87M |
| Net Cash | -455,953 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | 19.74M |
| Book Value Per Share | 0.09 |
| Working Capital | 6.75M |
Cash Flow
In the last 12 months, operating cash flow was -10.93 million and capital expenditures -1.90 million, giving a free cash flow of -12.83 million.
| Operating Cash Flow | -10.93M |
| Capital Expenditures | -1.90M |
| Free Cash Flow | -12.83M |
| FCF Per Share | -0.06 |
Margins
Gross margin is 41.34%, with operating and profit margins of -108.07% and -190.00%.
| Gross Margin | 41.34% |
| Operating Margin | -108.07% |
| Pretax Margin | -192.28% |
| Profit Margin | -190.00% |
| EBITDA Margin | -101.67% |
| EBIT Margin | -108.07% |
| FCF Margin | n/a |
Dividends & Yields
KHRNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.67% |
| Shareholder Yield | -24.67% |
| Earnings Yield | -9,625,950.00% |
| FCF Yield | -5,530,816.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KHRNF has an Altman Z-Score of -3.62 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.62 |
| Piotroski F-Score | 2 |